Astrocyte elevated gene-1 regulates CCL3/CCR5-induced epithelial-to-mesenchymal transition via Erk1/2 and Akt signaling in cardiac myxoma

Shi,Ping; Fang,Changcun; Pang,Xinyan

doi:10.3892/or.2015.4081

Astrocyte elevated gene-1 regulates CCL3/CCR5-induced epithelial-to-mesenchymal transition via Erk1/2 and Akt signaling in cardiac myxoma

Authors:
- Ping Shi
- Changcun Fang
- Xinyan Pang
View Affiliations

Affiliations: Department of Emergency Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, P.R. China, Department of Cardiosurgery, Qilu Hospital of Shandong University, Jinan, Shandong, P.R. China
Published online on: June 25, 2015 https://doi.org/10.3892/or.2015.4081
Pages: 1319-1326

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In recent years, astrocyte elevated gene-1 (AEG-1) has been reported as a key mediator that is involved in the epithelial-to-mesenchymal transition (EMT) process. However, the mechanisms underlying CCL3/CCR5-AEG-1 pathway-mediated EMT in cardiac myxoma (CM) has not been well featured till now. We used immnohistochemistry and immunoblotting to assess the expression of CCR5 and AEG-1 in 30 cases of CM tissues and cells. Subsequently, cultured CM cells were treated with si-AEG-1 or si-CCR5 and then subjected to in vitro assays. We observed that CCR5 and AEG-1 proteins were highly expressed in CM tissues (73.3 and 76.7%, respectively) and closely correlated with tumor size (>5 cm). Importantly, we validated the expression of AEG-1, p-Erk1/2, p-Akt, vimentin, N-cadherin and MMP2 increased in the CM cell with CCL3 treatment in a time- and concentration-dependent manner. When CM cells were treated with si-CCR5, the expression of AEG-1, p-Erk1/2, p-Akt, vimentin, N-cadherin and MMP2 was downregulated. In addition, when CM cells were treated with si-AEG-1, the expression of p-Erk1/2, p-Akt, vimentin, N-cadherin and MMP2 was also downregulated. Using the cell cycle and proliferation assay, the knockdown of AEG-1 inhibited the entry of G1 into S phase and the proliferation capacity of CM cells. In conclusion, AEG-1 mediates CCL3/CCR5-induced EMT development via both Erk1/2 and Akt signaling pathway in CM patients, which indicates CCL3/CCR5-AEG-1-EMT pathway could be suggested as a useful target to affect the progression of CM.

View Figures

View References

1	Lee HS, Kim HK, Park EA, Kim KH, Kim YJ and Sohn DW: Left atrial intramural hematoma after removal of atrial myxoma: Cardiac magnetic resonance in the differential diagnosis of intracardiac mass. J Cardiovasc Ultrasound. 22:205–208. 2014. View Article : Google Scholar
2	Watanabe H, Nara I, Yamaura G, Iino K, Iino T, Shimbo M, Seki K and Ito H: Blood balloon induced by an atrial myxoma in the heart. Circulation. 130:2351–2353. 2014. View Article : Google Scholar : PubMed/NCBI
3	Anpalakhan S, Ramasamy D and Fan KS: An unusual presentation of atrial myxoma. Singapore Med J. 55:e156–e158. 2014. View Article : Google Scholar
4	Choi K, Jung D, Hong SW, Jeon Y and Kim SO: Extra cardiac tumor misdiagnosed as a left atrial myxoma. Korean J Anesthesiol. 67(Suppl): S67–S68. 2014. View Article : Google Scholar
5	Di Vito A, Mignogna C and Donato G: The mysterious pathways of cardiac myxomas: A review of histogenesis, pathogenesis and pathology. Histopathology. 66:321–332. 2015. View Article : Google Scholar
6	Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ and Fisher PB: Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002. View Article : Google Scholar : PubMed/NCBI
7	Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet JM, et al: Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest. 119:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
8	Lee SG, Jeon HY, Su ZZ, Richards JE, Vozhilla N, Sarkar D, Van Maerken T and Fisher PB: Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene. 28:2476–2484. 2009. View Article : Google Scholar : PubMed/NCBI
9	Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poorprognosis breast cancer. Cancer Cell. 15:9–20. 2009. View Article : Google Scholar :
10	Liu K, Guo L, Miao L, Bao W, Yang J, Li X, Xi T and Zhao W: Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells. Anticancer Drugs. 24:494–503. 2013. View Article : Google Scholar : PubMed/NCBI
11	Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, et al: Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res. 14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
12	Weber CE, Li NY, Wai PY and Kuo PC: Epithelial-mesenchymal transition, TGF-β, and osteopontin in wound healing and tissue remodeling after injury. J Burn Care Res. 33:311–318. 2012. View Article : Google Scholar : PubMed/NCBI
13	Soria G and Ben-Baruch A: The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 267:271–285. 2008. View Article : Google Scholar : PubMed/NCBI
14	Mencarelli A, Graziosi L, Renga B, Cipriani S, D'Amore C, Francisci D, Bruno A, Baldelli F, Donini A and Fiorucci S: CCR5 antagonism by maraviroc reduces the potential for gastric cancer cell dissemination. Transl Oncol. 6:784–793. 2013. View Article : Google Scholar
15	Sasaki S, Baba T, Shinagawa K, Matsushima K and Mukaida N: Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice. Int J Cancer. 135:1297–1306. 2014. View Article : Google Scholar : PubMed/NCBI
16	Sakamoto H, Sakamaki T, Kanda T, Tsuchiya Y, Sato M, Sato H, Oyama Y, Sawada Y, Tamura J, Nagai R, et al: Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells. Circ J. 68:488–493. 2004. View Article : Google Scholar : PubMed/NCBI
17	He W, He S, Wang Z, Shen H, Fang W, Zhang Y, Qian W, Lin M, Yuan J, Wang J, et al: Astrocyte elevated gene-1 (AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling. BMC Cancer. 15:1072015. View Article : Google Scholar
18	Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y, Hao M, Sheng S, Sun Y, Zhang H, et al: Huaier polysaccharides suppresses hepatocarcinoma MHCC97-H cell metastasis via inactivation of EMT and AEG-1 pathway. Int J Biol Macromol. 64:106–110. 2014. View Article : Google Scholar
19	Khorramdelazad H, Mortazavi Y, Momeni M, Arababadi MK, Khandany BK, Moogooei M and Hassanshahi G: Lack of correlation between the CCR5-Δ32 mutation and acute myeloid leukemia in Iranian patients. Indian J Hematol Blood Transfus. 31:29–31. 2015. View Article : Google Scholar
20	Shi Y, Wu H, Zhang M, Ding L, Meng F and Fan X: Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 8:892013. View Article : Google Scholar : PubMed/NCBI
21	Shih JY and Yang PC: The EMT regulator slug and lung carcinogenesis. Carcinogenesis. 32:1299–1304. 2011. View Article : Google Scholar : PubMed/NCBI
22	Chowdhury I, Thompson WE and Thomas K: Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway. J Cell Physiol. 229:998–1004. 2014. View Article : Google Scholar
23	Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S and Raymond E: MEK in cancer and cancer therapy. Pharmacol Ther. 141:160–171. 2014. View Article : Google Scholar
24	Wang F, Ke ZF, Wang R, Wang YF, Huang LL and Wang LT: Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway. Biochem Biophys Res Commun. 452:933–939. 2014. View Article : Google Scholar : PubMed/NCBI
25	Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z and Zhou J: CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett. 358:124–135. 2015. View Article : Google Scholar
26	Bhat FA, Sharmila G, Balakrishnan S, Arunkumar R, Elumalai P, Suganya S, Raja Singh P, Srinivasan N and Arunakaran J: Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem. 25:1132–1139. 2014. View Article : Google Scholar : PubMed/NCBI
27	Yao C, Lv S, Han M, Zhang J, Zhang Y, Zhang L, Yi R, Zhuang D and Wu J: The association of Crk-like adapter protein with poor prognosis in glioma patients. Tumour Biol. 35:5695–5700. 2014. View Article : Google Scholar : PubMed/NCBI
28	Srivastava J, Robertson CL, Rajasekaran D, Gredler R, Siddiq A, Emdad L, Mukhopadhyay ND, Ghosh S, Hylemon PB, Gil G, et al: AEG-1 regulates retinoid X receptor and inhibits retinoid signaling. Cancer Res. 74:4364–4377. 2014. View Article : Google Scholar : PubMed/NCBI